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Using USRDS generated hospitalization tables to compare local dial-
ysis patient hospitalization rates to national rates. Hospitalization tables
of the U.S. Renal Data System allow description of national hospitaliza-
tion rates among incident and prevalent dialysis patients in five-year age
groups. These rates are further stratified by sex, race, and four primary
disease categories. Based on these tables derived from the data on over
250,000 incident and prevalent patients during 1991 to 1993, a methodol-
ogy is described that allows comparison of local (for example, dialysis
facility) or regional "first admission" rates among incident and prevalent
dialysis patients to the national rates. A standardized hospitalization ratio
is introduced to facilitate such comparisons, and methods for assessing
statistical significance are discussed. Since this methodology allows adjust-
ment for age, race, sex, and primary disease, it can serve as useful tool for
dialysis research. It can also be used at the dialysis facility level, alone or
in conjunction with the standardized mortality ratio, to facilitate local
quality assurance.
The U.S. Renal Data System (USRDS) maintains a vast
database of information on the end-stage renal disease (ESRD)
population of the United States. The primary source of USRDS
data is the Health Care Financing Administration (HCFA), and
consists primarily of information on patients who are in the
Medicare system. It is estimated that the data encompass 93% of
all ESRD patients. The data are updated and summarized yearly
in the reference tables of the USRDS Annual Data Report. The
wealth of information available from the USRDS can be put to
use in a variety of valuable ways. The intent of this article is to
show how information on patient hospitalization can be used in a
simple way to construct a standardized hospitalization ratio
(SHR). The SHR is derived in a similar manner to the standard-
ized mortality ratio (SMR) proposed in Wolfe et al [1], and should
prove valuable to dialysis facilities interested in comparing their
local hospitalization experience to the national norm.
Wolfe et a! [1] describe a methodology for comparing the
observed mortality rate in a specific group of ESRD patients to
national average rates, adjusted for age, race, and primary cause
of ESRD. The national rates are calculated based on the refer-
ence tables found in the 1990 USRDSAnnua1 Data Report [2]. The
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primary mode of comparison proposed in Wolfe et al [1] is the
SMR, which is defined as the ratio of the observed number of
deaths in the specific patient group under study (such as, a local
dialysis facility) to the expected number of deaths in that group,
where the expected number of deaths is calculated using the
national ESRD death rates. Values of the SMR larger than 1.0
indicate higher mortality relative to the national average, and
values less than one indicate lower than average mortality. Since
the rates are adjusted for age, race, and primary disease, discrep-
ancies between the observed and expected rate are attributable to
other, unmeasured factors as well as random variation.
Adjusted comparisons to the national ESRD average using the
SMR have been proposed as a method by which administrative
databases like the one maintained at the USRDS can be used in
a quality enhancement program [3]. Such programs can be
implemented at dialysis facility or treatment protocol levels or at
more aggregated levels such as a dialysis chain or ESRD network
organization. For example, a dialysis facility could use SMR
information to identify themselves as having higher (or lower)
than expected mortality, and subsequently examine other factors
in order to determine its source(s). However, hospitalization
patterns provide another important source of facility-based infor-
mation, and present a useful supplementary measure to the SMR.
In addition to mortality reference tables, the USRDS publishes
reference tables in its Annual Data Report that describe the
national hospitalization experience for the Medicare population
of ESRD patients over a recent three-year period by demographic
and primary disease group [4], These data are abstracted from the
hospital records, bills, and patient insurance claims available from
HCFA. Information on the number of patient hospital admissions
and years at risk is available, and can serve as a standardized
source of morbidity information in much the same way as the
mortality data. In particular, it provides the basis for the construc-
tion of the SHR. This paper describes such reference tables, and
then explains how this information may be used to calculate the
SHR for a particular facility or geographic region. For reasons to
be explained, a patient will only be allowed to contribute the first
hospitalization event (and corresponding risk time) experienced
in a given time period to the SHR. This allows the use of
straightforward and familiar methods for evaluating statistical
significance and calculating confidence intervals which parallel
those used for the SMR [1, 3]. Some advantages and disadvan-
tages of using the SHR relative to other possible methods for
571
572 Strawdennan et a!: USRDS generated hospitalization tables
characterizing the morbidity experience of the group in question
relative to national levels are also discussed.
Methods
The USRDS 1995 Annual Data Report [4] reports hospital
admissions and patient years at risk for 1991 to 1993 in its
Reference Table H.1. This information is presented by age group
(0—19, 20—44, 45—64, 65+), race (Black, White, Asian, Native
American, Unknown), sex, and primary disease (or diagnosis)
group (Diabetes, Glomerulonephritis, Hypertension, Other/Un-
known, and Missing), and is available for all dialysis patients at the
beginning of 1991. This information is used to create the national
hospitalization rate tables described below. Before this is done, it
will be useful to discuss how the rate tables will be calculated, and
in particular why we have chosen to use only the first hospitaliza-
tion event for each patient in a given study period.
It is easiest to motivate this choice by first recognizing that it is
the SHR we are ultimately interested in estimating and drawing
inferences about. The event used in calculating the SMR is
"patient death," something which obviously occurs only once. This
is directly related to the central assumption underlying the
calculation and statistical properties of the SMR, which is that the
random variability in the observed mortality count approximately
follows a Poisson distribution [5]. The necessary assumptions are
actually somewhat weaker; see Hoem [6] for a more technical but
illuminating discussion.
In contrast to mortality counts, the total number of hospital
admissions may exceed the number of eligible patients in a given
year because each patient may experience more than one hospi-
talization in that time period. This apparently minor distinction
between hospitalization and mortality rates has subtle and impor-
tant implications for the estimation of and inference for a
standardized hospitalization ratio based on all of the observed
hospitalizations per patient. The issues are rather technical, and
we simply mention here that the source of the problem is the
correlation (or, more accurately, serial dependence) between
successive hospitalization events for each individual. Failure to
properly account for this dependence can have a deleterious effect
on the calculation and interpretation of standardized hospitaliza-
tion rate based on total admissions as well as its corresponding
estimated standard error. We discuss these problems in more
detail in the Discussion section.
Because of these issues, we calculate hospitalization rates using
only a patient's first hospitalization during the study period as the
event of interest. The time at risk for first hospitalization is
determined accordingly. In this way, each patient contributes at
most one observed event (and corresponding risk time) to the
calculated rate, and the method is in this sense identical to the
calculation of mortality rates. By emulating the calculation of the
SMR, we can ensure that valid inferences may be drawn using
relatively simple methods.
To illustrate how the calculations are done, consider a dialysis
patient who is eligible at the start of 1991 and who is hospitalized
three times during the study period (1 year), the first time being
March 2. This person will only contribute the first observed
hospitalization for that year, and the period at-risk for first
hospitalization of that patient will be the length of time from
January ito March 2 (that is, the days until a first hospitalization),
which is 61 days. Alternatively, a patient that is not hospitalized
during the year while on dialysis contributes zero observed first
hospitalizations. The patient's at-risk period is one year (365 days)
or time to death (in days) if a patient died without any hospital-
izations since January 1. If a patient is transplanted during the
year, the days at risk are censored three days prior to the date of
transplantation. This is because transplantation, which is not
considered to be a morbid event, always results in a hospitaliza-
tion. This hospitalization, which is not attributed to dialytic
therapy and therefore not counted, is usually no more than two
days prior to transplantation. Thus, censoring as indicated avoids
capturing the hospitalization time prior to transplant as part of
"at-risk" period. Ignoring this fact would result in an overcount of
days at risk and deflates the value of the SHR towards zero.
This method is essentially the one used to calculate the national
"first hospitalization rates" for dialysis patients in Tables 1 and 2.
A more complete descriptions of data sources, patient eligibility
rules, and the actual rate calculations are given later in this
section. The national rates, which are expressed in terms of first
hospitalizations per patient-year, are specific to patient age, race,
sex, and primary disease. The "All" disease category includes
patients for whom the USRDS is missing information on diagno-
sis, since it is assumed that the dialysis unit (or specific compari-
son locality) has that information on all of their patients. The
"Diabetic" disease category consists of those patients whose
primary cause of ESRD is reported to be diabetes. The "Non-
Diabetic" category includes patients diagnosed as having hyper-
tension, glomerulonephritis, or "other." The stratification by
Diabetic/Non-Diabetic instead of by the four primary disease
categories used for the SMR [1] is done to minimize possible
misclassification errors across the disease categories. Those pa-
tients for whom the USRDS is missing information on diagnosis
have been excluded. The reason is that the dialysis unit is less
likely to have patients with a missing diagnosis, and hence
typically would include patients only with known diagnoses (that
is, in the diabetes, glomerulonephritis, hypertension and "other"
categories). These conventions primarily serve to increase the
usefulness of these tables to dialysis facilities.
To increase the stability of the calculated rates, we have pooled
the available data over the period of 1991 to 1993. Since the
national rates are assumed to be fixed when calculating the SHR,
the fact that they are pooled does not affect the statistical
properties of the SHR. In addition, to make the rates more
"age-specific", we have further stratified the data into five-year
age groups, with the exception of the very young and very old.
Because of the fine stratification, some cells still have a small
number of hospital admissions, even after pooling the data.
Empirical work suggests that a reasonable criterion for defining a
cell as "too small" is if the number of first hospitalization events
is less than 30 in total over the three years. Cells for which this
occurs are aggregated over the stratification factors until the total
number of events exceeds 30.
The aggregation is done first over sex, and then over diagnosis.
This is done under the assumption that the national rates vary less
by gender than by diagnosis. Any cells with less than 30 events
after that point are suppressed. From Table lit is evident that this
was not particularly problematic for Blacks and Whites. However,
there is much less information available at this level of stratifica-
tion for Native Americans and Asians, leading to a greater
percentage of aggregated and suppressed cells in Table 2. Patients
corresponding to the blank cells in Table 2 must be excluded from
any calculations; such cases should not be reclassified due to the
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Table 1. First hospitalization rates during 1991—1993 per patient year at risk among eligible Medicare hemo- and peritoneal dialysis patients, alive
on Januaiy 1 by age, race, sex, and primary disease
Age as of Jan. 1
Diagnosis
All Diabetic Non-diabetic
Black White Black WhiteBlack White
Males014
15—19
20—24
25—29
30—34
35—39
40—44
45—49
50—54
55—59
60—64
65—69
70—74
75—79
80—84
85+
Total"
1.450
1.058
0.983
1.059
1.092
1.038
0.986
0.980
1.000
1.035
1.043
1.207
1.257
1.391
1.504
1.616
1.090
1.023
0.843
0.802
0.934
0.982
0.964
0.937
0.996
1.095
1.116
1.151
1.274
1.327
1.421
1.455
1.601
1.182
1.450"
1.058a
2.176
1.788
1.826
1.621
1.356
1.271
1.241
1.212
1.193
1.310
1.437
1.545
1.690
1.223
1.323
1.023a
0.843a
1.429
1.623
1.584
1.453
1.447
1.374
1.454
1.433
1.383
1.462
1.539
1.649
1.724
1.896
1.475
1.529
1.084
0.962
1.000
1.051
1.008
0.943
0.930
0.914
0.971
0.991
1.175
1.190
1.355
1.470
1.685
1.042
1.095
0.882
0.754
0.798
0.790
0.772
0.761
0.842
0.939
0.973
1.053
1.205
1.274
1.382
1.424
1.588
1.103
Females
0—14
15—19
20—24
25—29
30—34
35—39
40—44
45—49
50—54
55—59
60—64
65—69
70—74
75—79
80—84
85+
Total"
1.255
1.287
1.335
1.319
1.223
1.158
1.102
1.140
1.188
1.201
1.275
1.346
1.381
1.430
1.528
1.831
1.283
0.894
1.025
1.023
1.121
1.134
1.057
1.084
1.153
1.194
1.217
1.348
1.436
1.561
1.618
1.672
1.695
1.357
1.255"
1.287a
2.240
2.505
1.965
1.708
1.554
1.444
1.475
1.383
1.434
1.452
1.483
1.536
1.706
1.936
1.485
0.894"
1.025"
1.880
1.834
1.725
1.639
1.490
1.572
1.625
1.527
1.595
1.646
1.775
1.806
1.827
1.998
1.658
1.251
1.270
1.295
1.183
1.157
1.096
1.019
1.042
1.056
1.082
1.152
1.255
1.310
1.380
1.485
1.806
1.195
0.933
1.033
0.948
0.962
0.952
0.877
0.954
1.006
1.000
1.035
1.190
1.312
1.460
1.556
1.641
1.661
1.242
Blacks and Whites only.
National overall rates for Blacks and Whites are respectively 1.186 and 1.261.
National overall rates for Males and Females are respectively 1.135 and 1.307.
The national overall rate is 1.216.
"Due to small cell sizes, rates are not diagnosis specific
b
"Total rate" listed under the All category collapsed over age and diagnosis
potential for distorting the rates. Cell-specific information on how
much the data were aggregated is given in the footnotes of each
table. Also given in the footnote of each table are the overall,
race-specific, and gender-specific national rates.
Defining the patient cohort
To describe how the hospitalization rates in Tables 1 and 2 are
calculated, the criteria used to select patients must first be
defined. The data are abstracted from the HCFA Standard
Analysis Files (SAF) for the years 1991 to 1993. The data for each
year contain all data which became available for that period
through June of the following year. The observed number of first
hospitalizations and corresponding risk time for each of the years
1991 to 1993 is calculated for eligible incident and prevalent
hemo- and peritoneal dialysis patients. In order for a patient to be
classified as incident in a given year, their 90th day of ESRD must
fall between January 1 and December 31 of that year. Prevalent
patients, which include both never-transplanted and previously
transplanted patients, have reached their 90th day of ESRD prior
to January 1 of the relevant year.
To be deemed eligible in a given year, any incident or prevalent
patient must be on dialysis for at least 60 days by their study entry
data for that year. The default study entry date for an incident
patient is the 91st day of ESRD, and for prevalent patients it is
January 1. If any incident or prevalent patient is in the hospital on
their default study entry date, the study entry date is redefined to
be the first day following discharge from that hospitalization.
These criteria exclude any patients having had a transplant failure
between November 1 of the prior year and January 1 of the study
year. The maximum possible at-risk period for any eligible patient
in a given year is defined as the time from study entry to
December 31. The corresponding time at risk is calculated from
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Table 2. First hospitalization rates during 1991—1993 per patient year at risk among eligible Medicare hemo- and peritoneal dialysis patients alive
on January 1 by age, race, sex, and primary disease in Native Americans and Asians only. Suppressed cells consist of less than 30 total
hospitalizations over 1991—1993.
Age as of Jan. 1
Diagnosis
All Diabetic Non-diabetic
Nat. Am. Asian Nat. Am. AsianNat. Aim Asian
Male
0—14 — — — — — —
15—19 — 0.555a 0555h — 0.536'
20—24 0.901a 0.538 0901b 0.57l 0.84P' 0.491
25—29 1.322 0.503 1163h 0652b I111C 0.435
30—34 0.877 0.482 1.654a 1.903a 0.743 0.453
35—39 0.807 0.479 1.401a 0526b 0.652 0.457
40—44 1.115 0.671 1.728 0.963 0.722 0.628
45—49 1.084 0.773 1.077 1.162 1.067 0.626
50—54 1.148 0.741 1.324 1.023 0.722 0.598
55—59 1.136 0.804 1.218 0.975 0.938 0.673
60—64 1.279 0.867 1.280 1.009 1.256 0.718
65—69 1.158 0.782 1.392 0.845 0.945 0.738
70—74 1.344 0.853 1.792 1.038 1.044 0.792
75—79 1.063 0.906 1.183 1.066 0.935 0.838
80—84 1.035 0.902 1.138C 1.063 1.314" 0.856
85+ — 0.961 — 0892b — 0.954
Total" 1.126 0.755 1.323 0.986 0.920 0.666
Females
0—14 — — — — — —
15—19 — 0.555" 0555h — 0.536"
20—24 0.901" 0.615 0901h 057l 0.841" 0.640
25—29 1.047 0.836 1.163" 0.652" 1.111' 0.834
30—34 1.020 0.815 1.654" 1.903' 0.721 0.638
35-39 1.075 0.572 1.674 0.526" 0.647a 0.518
40—44 0.977 0.604 1.208 1.035" 0.766 0.520
45—49 1.166 0.675 1.203 0.951 1.157 0.637
50—54 1.362 0.988 1.511 1.265 0.847 0.883
55—59 1.354 0.936 1.357 1.082 1.403 0.840
60—64 1.371 1.086 1.507 1.290 0.926 0.880
65—69 1.252 0.830 1.433 0.962 0.818 0.697
70—74 1.224 0.733 1.320 0.796 1.032 0.688
75—79 1.228 0.733 1.470 0.765 0.904 0.706
80—84 1.372 0.525 1.138" 0.842" 1.389 0.499
85+ — 0.794 — 0892h — 0.911"
Total 1.249 0.786 1.421 1.012 0.968 0.686
National overall rates for Native Americans and Asians are respectively 1.192 and 0.770.
National overall rates for Blacks and Whites are respectively 1.186 and 1.261.
National overall rates for Males and Females are respectively 1.135 and 1.307.
The national overall rate is 1.216.
Due to small cell sizes, rates are not sex-specific
b Due to very small cell sizes, rates are neither sex nor diagnosis specific
C
"Total rate" listed under the All category collapsed over age and diagnosis
the study entry date until a hospitalization or censoring event
occurs. Eligible patients are censored (withdrawn) on the date of
death or three days prior to the date of transplant.
These restrictions, which we collectively refer to as the "60-day
rule," help to ensure that all hospitalizations on which Medicare
is the primary payer are captured. Due to the way in which the
data are obtained from HCFA, the rates are based on all of the
data which will ever be available to the USRDS through the
HCFA SAF's, and in this sense may be considered complete.
Hospitalizations not in the HCFA database at the time the file is
frozen are not captured due to the fact that the data are
unavailable to HCFA and hence to the USRDS. This includes, but
may not be limited to, hospitalizations not covered by Medicare.
Calculation of the national rates
The national first hospitalization rates in Tables 1 and 2 are
compiled on a per-patient per-year basis. This means that the
eligibility criteria are individually applied to each patient in the
USRDS database for each of the years 1991, 1992, and 1993, and
that the eligibility of a patient in a given year depends only on his
or her personal characteristics as of their first possible study entry
date for that year. Since the rates are pooled over three years, the
same patient may contribute hospitalization data in each of the three
years, but only the first hospitalization event in any given year.
Based on the criteria described in the last section, there were
over 250,000 unique eligible patients for the period of 1991 to
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1993. However, since patients may contribute data to more than
one year, the effective number of eligible patients on which these
national rates are based is 470,114, with 267,066 "first" admissions
in total. This represents nearly 92% of all hospitalization data
available to the USRDS under this system of calculation. Of the
remaining 8%, less than 0.07% were excluded due to the restric-
tions on the eligibility of previously transplanted patients. The rest
did not have dialysis bills paid by Medicare prior to the start of the
period.
Each hospitalization rate in Tables 1 and 2 is the ratio of the
yearly number of observed first hospitalizations among eligible
dialysis patients between 1991—1993 to their corresponding total
follow-up time. That is, each pooled national rate is calculated
using the formula
O9 + O• + 0.93
National hospitalization rate in subgroupj = ' ' '
13,91 + 1392 + F,93
where °j,91' 0j,92, and °j93 are the observed number of hospital
first admissions in subgroupj for each of the three years, and Fy91,
1392, and 1393 are the corresponding follow-up times (in patient-
years), calculated as described earlier. Note, for example, that
01,91 is the number of patients in subgroup j who were ever
hospitalized in 1991, and not the total number of hospitalizations
in 1991. Correspondingly, 13.91 is the total time at risk for first
hospitalization, and is calculated based on all eligible patients in
1991, not just those who had at least one hospitalization.
For example, the hospitalization rate in Table I for diabetic
white male dialysis patients between the ages of 65 to 69 who
satisfied the eligibility criteria for each year between 1991 and
1993 is 1462. The cumulative number of eligible patients in this
subgroup over the three year period is 6908, with 1936, 2330, and
2642 patients eligible in 1991, 1992, and 1993, respectively. There
were 9554 total hospitalizations and 4140 first hospitalizations
during this three year period, with first admissions numbering
= 1159, 01.92 = 1393, and 01:93 = 1588. These 6908 patients
contributed 2830 total patient-years of follow-up time (F1:91 =
765, F1:92 = 934, and F1.93 = 1130) to first hospitalization under
the rules outlined in the previous section. The resultant hospital-
ization rate for this subgroup, expressed in units of "hospital first
admissions per patient year at risk for first hospitalization while
receiving dialysis therapy," is therefore 4140/2830, or 1.462 as
stated.
Calculating the SHR for specific patient study populations
To compare the hospitalization experience in a local study
population to the national average using the SHR, the follow-up
time must first be calculated for each specific patient subgroup in
the local study population that is also listed in Tables 1 and 2. The
expected number of first hospitalizations is then computed by
multiplying the national subgroup rate by the total person time at
risk in that subgroup, and then summing over all subgroups.
Follow-up time used in computing the rates in Tables 1 and 2 is
in terms of patient-years at risk for first hospitalization. Given the
total number of days at risk for subgroup j within our study
population, we may then calculate the expected number of first
hospitalizations in that subgroup as follows:
Expected number
of first
hospitalizations
in subgroupj
of study population
The total number of expected first hospitalizations for the study
population is then obtained by summing the expected number of
first hospitalizations in each subgroup over all of the subgroups
listed in Tables 1 and 2. If a particular subgroup is not represented
in the study population, then both the observed and expected
numbers of first hospitalizations is set to zero for that subgroup.
The standardized hospitalization ratio may now be defined as
SHR —
Observed number of first hospitalizations in study population
Expected number of first hospitalizations in study population
A ratio that is larger than 1.0 indicates a higher than average
hospitalization rate, and a value less than 1.0 indicates a lower
than average hospitalization rate. For example, a value of 0.90
indicates that the observed hospitalization rate is 10% lower than
expected from the national average.
To illustrate these calculations, consider a hypothetical study
population at one facility consisting of 14 eligible dialysis patients.
Suppose three of the patients are Asian and one is Native
American, with all four corresponding to a suppressed cell in
Table 2. Since Table 2 has no information about the rates for
these patients, they must be excluded from the calculations,
leaving 10 eligible patients. The length of the study period is from
January 1, 1992 to December 31, 1992. In order to count
hospitalizations on January 1, patient eligibility is determined as
of December 31, 1991 for each patient. Those patients which
became incident during this period are started from their entry
date. Patient follow-up is determined as described earlier, with a
maximum possible follow-up time of 366 days since 1992 was a
leap year. This information is summarized in Table 3. There are
eight columns, the first four delineating the age, race, sex, and
primary disease of the patients. The next column gives the number
of days at risk for first hospitalization. The fifth column, "National
Rate," is the corresponding rate from Table 1. The "Expected
First Hospitalizations" is obtained by first dividing the "Days at
Risk" by 365, and then multiplying the result by the "National
Rate." The numbers are not rounded up or down to the nearest
integer. Finally, the "Observed First Hospitalizations" is a binary
variable indicating whether they entered the hospital or not
during that year.
Based on the above formula, the observed SHR is thus
6/10.0782, or 0.595. Hence, this particular facility is estimated to
have a 40% lower hospitalization rate than the national average.
Methods for assessing the statistical significance of this result (for
example, testing if the true SHR differs from 1.0) are discussed in
the next section.
These calculations can be done for a small dataset using a hand
calculator. For larger datasets, the necessary calculations are
easily automated in a spreadsheet package such as Excel or Lotus.
The procedure is exactly the same as that described in Wolfe et al
[1], except that a column for "sex" should also be added. It is
important to remember that the rates in Tables 1 and 2 of this
paper are calculated in units of patient years (that is, per 365
days), and consequently calculations which utilize these rates must
National rate
= forsubgroupj x
from Table 1
Days at risk in subgroupj
in study population
365 days
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Table 3. Example calculation comparing local and national dialysis patient hospitalization rates
Age Race Sex
Primary
disease
Days
at risk
National
ratea
First hospitalizations
Expectedb Observed
76 White Male Hyperten. 217 1.382 0.8246 1
53 Black Female Hyperten. 366 1.056 1.0614 0
29 White Male Glomer. 328 0.798 0.7216 1
37 White Female Other 366 0.877 0.8784 0
23 Black Female Diabetes 185 2.240 1.1285 0
65 Black Male Diabetes 219 1.310 0.7884 1
72 White Male Hyperten. 263 1.274 0.9205 1
70 Black Male Glomer. 278 1.190 0.9174 1
83 White Female Glomer. 324 1.641 1.4580 1
78 Black Female Other 363 1.380 1.3794 0
Total (sum of observed and expected hosp.) 10.0782 6
1a Rates from Table
bNational rate X days at risk — 365
have have follow-up time expressed in like units before calculating
the expected number of first hospitalizations.
In order to ensure valid and meaningful comparisons, strict
adherence to the entry criteria and calculation of follow-up time
described above must be observed in the calculation of the SHR
for any study population. In particular, this refers to the fact that
one should use these tables for calculations for study periods
which are on year in length and which have start and stop dates of
January 1 and December 31. This does not mean that each patient
must be observed for this entire period; it only implies that the
earliest study entry date for any eligible patient is January 1, and
that the maximum follow-up time for any patient is the time from
study entry to December 31. The reason for requiring this fixed
study window is that there is a probable seasonal effect for
hospitalization admissions. For example, there may be an increase
in the number of hospitalizations in the week following January 1
due to patients deferring admission until after the holidays. The
calculations in Tables 1 and 2 count those hospital admissions in
the numerator, and the times at risk for these hospitalizations are
rather short. For a dialysis facility having an unusually high
number of admissions in the first few weeks of January 1992, the
value of the calculated SHR may vary significantly depending
upon the study start date chosen. Suppose that, instead of starting
the study on January 1, 1992, the facility calculated the SHR for
a year long period beginning in February, 1991. Then, while the
number of admissions is the same in either calculation, the at-risk
period for those patients admitted in the few weeks following
January 1 may change from a few weeks to 11 months. This biases
the value of the SHR towards zero. Biases in a similar or opposite
direction can occur when the maximum follow-up time is set
longer or shorter than one year.
Methods of statistical inference for the SHR
The SHR for a given locality (that is, facility) contrasts the
observed count of first hospitalizations to that expected if the
rates of first hospitalization in that locality were comparable (by
subgroup) to the national rate. Even if the rates are exactly the
same, differences between the observed and expected number of
hospitalizations can occur by chance. Chance variation in the SHR
is contributed by each patient in the local study population, and
slight perturbations in this study population would result in a
slightly different value of the SHR. Conceptually, one may view
these variations in the SHR as being variations about a true,
underlying SHR. The latter is a fixed but unknown quantity that
relates the hospitalization experience over the set of all patients
similar to those in the particular study population to the national
average. Hence, a distinction must be made between the observed
SHR and the unknown underlying SHR.
Various methods for comparing local hospitalization rates to
national rates using the observed SHR are available. For example,
suppose that a facility is interested in testing whether their
observed hospitalization experience coincides with the national
average. One statistic appropriate for testing this hypothesis is
4(JAE)2
where A is the observed number of first hospitalizations and E is
the corresponding expected number calculated using the rates
from Tables 1 and 2 [5]. Under the null hypothesis that the SHR
is equal to 1.0 (that is, that the hospitalization rates in the facility
are the same as the national rates), the sampling distribution of
is well-approximated by a chi-square distribution with 1 degree-
of-freedom as long as the expected number of hospitalizations is
5 or more (E  5). Two other commonly used formulae for testing
the same hypothesis are the uncorrected and continuity-corrected
chi-square statistics [3, 5]. A test based on the Poisson distribution
is also possible and is described in [3].
If the value of is larger than 3.84, then the SHR is said to be
significantly different from 1.0 with a P value that is smaller than
0.05, indicating that the observed difference is not likely due to
chance. If the P value is larger than 0.05, the difference is often
labeled as insignificant and attributed to chance variation. Re-
turning to the example in Table 3, we have
= 4(/6 — \I10.0782)2 =2.10
which is less than 3.84. Hence, this difference is not statistically
significant at the 0.05 level (that is, P > 0.05).
An alternative method for testing the above hypothesis is to
place a confidence interval about the observed SHR. For example,
if the lower (upper) limit of a 95% confidence interval for the true
underlying SHR is greater (less) than 1.0, then the null hypothesis
of equality is rejected. The confidence interval also supplies a
plausible range for the true SHR. A reasonably accurate method
for calculating lower (L) and upper (U) confidence limits that only
requires simple calculations is the following:
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i z3L=
A+1( 1 z \3
= —
9(A + 1) +
where A and E are defined as above [3, 5]. The confidence interval
for the underlying SHR is then given as [L, U]. If A = 0, then by
convention L = 0. The term Z12 is set to 1.96 for a 95%
confidence interval that is desired. To compute a 90% confidence
interval for the underlying SHR, set Z12 = 1.645. In the example
of Table 3, we have A = 6 and E = 10.0782. The lower and upper
limits for a 95% confidence interval for the true SHR are
respectively L = 0.217 and U = 1.296. The wide range of the
confidence limits indicates a fair amount of variability in the
observed SHR, and is consistent with the fact that it is based only
on 10 patients.
The local overall first hospitalization rate can be obtained by
multiplying the overall national first hospitalization rate by the
SHR. The national rate of first hospitalizations is 1.216, and is a
weighted average of the total rates in Tables 1 and 2. Then, we
have
Facility "first hospitalization" rate = 1.216>< (Facility SHR)
(1.216) (0.595) = 0.7235.
It is important to note that since the 95% confidence interval
for the SHR includes 1.0, the hypothesis of equality of the first
hospitalization rate at our hypothetical facility to the national first
hospitalization rate also cannot be rejected at the 0.05 level.
Discussion
The methodology described here allows adjusted comparisons
of hospitalization rates at a local (such as a facility) level to the
corresponding national norm. Such comparisons are also available
at the "single-cell" level (for example, black female hypertensive
patients aged 20 to 24), or at a broader level such as by gender or
dialytic modality. The latter approach has provided useful infor-
mation in a comparison between continuous ambulatory perito-
neal dialysis and hemodialysis [7]. The SHR represents a substan-
tial improvement over comparisons between crude (that is,
unadjusted) hospitalization rates. Its similarity with the SMR
implies that the SHR shares many of the advantages and disad-
vantages of the SMR that, among many other places, are dis-
cussed by Wolfe and his co-authors [1]. A particular advantage of
the SHR over other methods for characterizing morbidity levels
using hospitalization data is that there are simple methods for (i)
assessing its variability at the facility level and (ii) drawing valid
inference about the magnitude of the rate. However, the proposed
SHR is only one possible method for characterizing local hospi-
talization experience relative to the national average. Other
possibilities include total admissions, hospital days, and length of
stay; some limited descriptive analyses of USRDS hospitalization
data using such measures may be found in Habach et al [7]. Below,
we compare and contrast these methods with the proposed SHR.
Rates based on total admissions
A standardized total admissions rate (STAR) may be defined
based on all hospitalizations for all eligible patients since the
beginning of follow-up. Provided a reasonable estimator for the
STAR can be found, its main advantage over the proposed SHR
is that it provides a summary statistic for the total hospitalization
experience for a facility over a given study period. This is in
contrast to the SHR, which has a somewhat more nebulous
interpretation as the rate of yearly "first" hospitalizations. How-
ever, while the SHR may perhaps be a more difficult quantity to
interpret qualitatively, it may be a better measure of the scope of
the hospitalization experience at a particular facility since it is less
sensitive to chronic hospitalization patterns. Consider two facili-
ties, each having 10 patients. Facility 1 has two patients with five
admissions each in a given year, and eight patients having no
admissions. In Facility 2, each of the 10 people have one admis-
sion during the year. For the same patient mix and similar
expected counts (adjusted to national levels), a rate based on total
admissions is not able to differentiate the two facilities. In
contrast, the SHR for Facility 2 will be five times that for Facility
1, and more appropriately correctly singles out Facility 1 for a
more in-depth investigation.
A point estimate of the STAR can be computed similarly to the
SHR, provided one is willing to assume that each individual's
hospitalization rate is unaffected by the number and pattern of
previous hospitalizations. Such an assumption underlies the meth-
odology found in Glynn et al [8], who investigate hospitalization
rates among the New England elderly. There, it is assumed that (i)
the event (hospitalization) count for each individual follows a
different Poisson distribution with mean given by their respective
subgroup (age/race/sex/diagnosis) rate; and, (ii) the follow-up
time for each individual within a subgroup is the same. The
genesis and further description of the general model may be found
in Greenwood and Yule [I
In the case of observational hospitalization data in a fixed time
interval, these assumptions are unlikely to be met. For example,
follow-up times will certainly vary over individuals, and, more
importantly, there is every reason to expect that an individual has
an increased risk of being hospitalized soon after a previous
hospitalization than if farther away in time. There may also be a
cumulative effect of previous hospitalizations; that is, a person
with a long history of frequent hospitalization may be more likely
to be hospitalized than someone with fewer, infrequent hospital-
izations. Failure to properly account for such dependence can
lead to invalid inferences. Models for the analysis of recurrent
event data have been proposed in the statistical literature [10—13]
which are able to account, at least partially, for an individual's
hospitalization history. In principal, it is possible to construct a
valid STAR with well-understood statistical properties. However,
the models are more complex, require substantial additional
modeling assumptions, and preclude easy application at the
facility level.
Rates based on hospital days and stays
One could also consider computing a standardized hospital
days rate (SHDR) or length of stay rate (SLOSR). For example,
a SHDR may be defined as the ratio of total number of hospital
days per patient year to the total days at risk for hospitalization
per patient year. Correspondingly, the SLOSR may be defined as
the ratio of total number of hospital days per patient year to the
total number of admissions per patient year. The main advantage
of each of these measures over the proposed SHR is again that
each has a reasonably simple interpretation. Informally, the
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former characterizes the average number of days spent in the
hospital per days at risk, and the latter the average LOS per
admission. Both are thus useful descriptive measures with reason-
ably simple qualitative interpretations.
One advantage of the SHR over these two measures is that both
hospital days and LOS are known to vary more by region than do
hospital admission rates (especially first admissions). This raises
the question of whether standardization of hospital days and LOS
rates to national levels is reasonable. The linear correlations
between the SHR and the SHD and SLOS rates are respectively
0.74 and 0.08; rank correlations are of a similar magnitude. The
strong correlation between the SHDR and SHR indicates that
they will often convey similar information from the point of view
of relative comparisons between facilities. An empirical investiga-
tion into the rather low correlation between the SLOSR and SHR
shows that it is primarily due to the much greater variability in the
LOS rates. Another disadvantage is that, like the STAR, the
statistical properties of the SHDR and SLOSR rates are more
difficult to establish without requiring restrictive additional mod-
eling assumptions.
The SHR: A useful measure of comorbidity
The SHR is a useful representation of the scope of the hos-
pitalization experience in a given locality over a given time period.
An estimated SHR significantly above or below 1.0 indicates more
or less patients are being hospitalized than would be expected at
the national level. The SHR is indeed less sensitive than a STAR
to the level of comorbidity in any individual patient, and more
sensitive to the scope, or distribution, of comorbidity across all
patients in a facility. Arguably, from the point of view of evaluat-
ing facilities, it is the former which is more relevant. These
properties make the SHR useful from the point of view of the
dialysis facility, which can use it along with the SMR as part of a
self-evaluation process that is independent of the involvement of
government and other review agencies.
As with any numerical summary measure, the SHR should be
interpreted with caution. For example, a facility might find that
they have an SHR and SMR significantly higher than the national
norm. However, it would be a mistake to immediately conclude
that a statistically significant difference here represents a depar-
ture from "ideal care." For example, it could be that the patient
mix for that facility is far sicker (as measured by factors other than
age, race, sex, and cause of ESRD) than the national average.
Conversely, it is possible that the facility does not properly
sterilize its equipment, resulting in excess hospitalizations. In
either case, the observed differences merit investigation if only to
determine the source of the difference. Other summary measures
(such as SHD and SLOS rates) may be used to augment the
information provided by the SHR and SMR to provide a more
complete description of the morbidity/mortality experience at the
facility. In a like manner, a facility having both a low SMR and
SHR is not necessarily an indicator of better-than-average care.
Such differences could be due to patient mix or selection which
are not associated with the particular care practices of the facility,
or due to the fact that the care provided by the facility is above
average. In any event, the information provided by the SHR is
useful to the facility for continual self-evaluation and quality-of-
care assessments.
Overall, there is a positive correlation between hospitalization
and mortality rates [4], as would be expected from this discussion.
However, it should be noted that the SHR reflects a process of
care, whereas the SMR is a true outcome measure. This process
might be a liberal approach to hospitalization, where prophylactic
or early admissions may lead to a higher SHR. By itself, a high (or
low) SHR cannot necessarily be considered indicative of poor or
ideal care. This is also true of the SMR. However, certain
combinations of rates are potentially informative, and merit
investigation on the part of the facility. In particular, a low SHR
in combination with a high SMR may very well reflect a poor
process of care which subsequently leads to high mortality.
Utilization of the SHR methodology in concert with the widely
applied SMR analyses will provide new insights into dialysis
patient care. We propose these relatively easy methods primarily
for self-evaluations by dialysis facilities and for scientific investi-
gations into regional practice patterns.
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